Education
About Us
Working with TipRanks
Follow Us
Birgit C Schultes Insider Profile
4 Followers
Birgit C Schultes, EVP, Chief Scientific Officer at Intellia Therapeutics, holds 105.18K shares in Intellia Therapeutics (Ticker: NTLA). Most recently, Birgit C Schultes Sold 31 shares of Intellia Therapeutics on Oct 03, 2025 for an estimated value of $538.78.
Birgit C Schultes has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Birgit C Schultes's holdings
Insider Roles
EVP, Chief Scientific Officer
Roles that Birgit C Schultes holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Birgit C Schultes
Birgit C Schultes's Trading History
List of latest transactions for each holding click on a transaction to see Birgit C Schultes's performance on stock
You May Also Like
Birgit C Schultes insider profile FAQ
What is the percentage of profitable transactions made by Birgit C Schultes?
The percentage of profitable transactions made by Birgit C Schultes is ―.
What is the average return per transaction made by Birgit C Schultes?
The average return per transaction made by Birgit C Schultes is ―.
What stocks does Birgit C Schultes hold?
Birgit C Schultes holds: NTLA stocks.
What was Birgit C Schultes’s latest transaction?
Birgit C Schultes latest transaction was an Informative Sell of $538.78.
What was Birgit C Schultes's most profitable transaction?
Birgit C Schultes’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Birgit C Schultes's role in Intellia Therapeutics?
Birgit C Schultes's role in Intellia Therapeutics is EVP, Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.